Repositorio Dspace

Listar por tema "Neoadjuvant Therapy"

Listar por tema "Neoadjuvant Therapy"

Ordenar por:Orden:Resultados:

  • Martínez, María; Jiménez, Sara; Guzman, Florentina; Fernández, Marta; Arizaga, Elena; Sanz, Consuelo (WILEY-HINDAWI, 2022-07)
    BACKGROUND: Due to the high false negative rate (FNR) associated with sentinel lymph node biopsy (SLNB) after neoadjuvant systemic therapy (NAST), the standard surgical treatment for patients with an initially positive ...
  • Lluch, Ana; Barríos, Carlos-H; Torrecillas, Laura; Ruiz-Borrego, Manuel; Bines, José; Segalla, José; Guerrero-Zotano, Ángel; García-Saenz, José-A; Torres, Roberto; de-la-Haba, Juan; García-Martínez, Elena; Gómez, Henry-L; Llombart, Antonio; Salvador-Bofill, Javier; Baena-Cañada, José-M; Barnadas, Agusti; Calvo, Lourdes; Pérez-Michel, Laura; Ramos, Manuel; Fernández-Pérez, Isaura; Rodríguez-Lescure, Álvaro; Cardenas, Jesús; Vinholes, Jeferson; Martínez-de-Dueñas, Eduardo; Godes, María-J; Segui, Miguel-A; Antón, Antonio; López-Álvarez, Pilar; Moncayo, Jorge; Amorim, Gilberto; Villar, Esther; Reyes, Salvador; Sampaio, Carlos; Cardemil, Bernardita; Escudero, María-J; Bezares, Susana; Carrasco, Eva; Martín, Miguel; Corona, J; Jara, C; Cardemil, Bernardita; Toro, R; Pimentel, C; Hernando, B; Vicente, Esther; Zagame, L; Gil, M; García-Estevez, L; Rodríguez, C; de-la-Cruz, M-A; Tello, J-M; Campos, S; Lomas, M; Capdevile, D; Campos, M; Margeli, M; Andrés, R; Tusquets, I; Ballesteros, A; Guerrero, A; Arguello, M; Rodríguez, J-L; Muñoz, M; Florian, J; Azevedo, S; Mondragon, R; Peralta, J; Palomo, A-E; Barajas, L-J; Arcusa, A; Carranza, H; García, C; Umbria, C; Ales, José-E; López-Vega, J-M; Romeo, M; Valero, J; Alonso, J-L; Mathias, C; Gutiérrez, Félix; Adrover, E; Nunez, P; Mendiola, C; Cassinello, J; de-la-Huerta, A (AMER SOC CLINICAL ONCOLOGY, 2020-01-20)
    PURPOSE: Operable triple-negative breast cancers (TNBCs) have a higher risk of relapse than non-TNBCs with standard therapy. The GEICAM/2003-11_CIBOMA/2004-01 trial explored extended adjuvant capecitabine after completion ...
  • Sánchez-Alcoholado, Lidia; Laborda-Illanes, Aurora; Otero, Ana; Ordonez, Rafael; González-González, Alicia; Plaza-Andrades, Isaac; Ramos-Molina, Bruno; Gómez-Millan, Jaime; Isabel-Queipo-Ortuño, Maria (MDPI, 2021-09)
    Emerging evidence has suggested that dysbiosis of the gut microbiota may influence the drug efficacy of colorectal cancer (CRC) patients during cancer treatment by modulating drug metabolism and the host immune response. ...